Acceso abierto

Fingolimod exerts in vitro anticancer activity against hepatocellular carcinoma cell lines via YAP/TAZ suppression

Jiamin Du

Jiamin Du

Zhejiang Province Key Laboratory of Anticancer Drug Research, College of Pharmaceutical Sciences, Zhejiang UniversityHangzhou, China
Buscar este autor en
Sciendo|Google Scholar
Du, Jiamin
, 
Meijia Qian

Meijia Qian

Zhejiang Province Key Laboratory of Anticancer Drug Research, College of Pharmaceutical Sciences, Zhejiang UniversityHangzhou, China
Buscar este autor en
Sciendo|Google Scholar
Qian, Meijia
, 
Tao Yuan

Tao Yuan

Zhejiang Province Key Laboratory of Anticancer Drug Research, College of Pharmaceutical Sciences, Zhejiang UniversityHangzhou, China
Buscar este autor en
Sciendo|Google Scholar
Yuan, Tao
, 
Bo Zhang

Bo Zhang

Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of MedicineHangzhou, China
Buscar este autor en
Sciendo|Google Scholar
Zhang, Bo
, 
Xueqin Chen

Xueqin Chen

Department of Oncology, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People´s Hospital, Zhejiang University School of MedicineHangzhou, China
Buscar este autor en
Sciendo|Google Scholar
Chen, Xueqin
, 
Ning An

Ning An

Department of Pharmacy, Ningbo Medical Center Lihuili HospitalNingbo, China
Buscar este autor en
Sciendo|Google Scholar
An, Ning
, 
Qiaojun He

Qiaojun He

Zhejiang Province Key Laboratory of Anticancer Drug Research, College of Pharmaceutical Sciences, Zhejiang UniversityHangzhou, China
Buscar este autor en
Sciendo|Google Scholar
He, Qiaojun
, 
Bo Yang

Bo Yang

Zhejiang Province Key Laboratory of Anticancer Drug Research, College of Pharmaceutical Sciences, Zhejiang UniversityHangzhou, China
Buscar este autor en
Sciendo|Google Scholar
Yang, Bo
, 
Song Ye

Song Ye

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Second Affiliated Hospital, School of Medicine Zhejiang UniversityHangzhou, China
Buscar este autor en
Sciendo|Google Scholar
Ye, Song
 y 
Hong Zhu

Hong Zhu

  • Zhejiang Province Key Laboratory of Anticancer Drug Research, College of Pharmaceutical Sciences, Zhejiang UniversityHangzhou, China
  • Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People’s Hospital, Zhejiang University School of MedicineHangzhou, China
  • The Westlake Laboratory of Life Sciences and BiomedicineHangzhou, China
Buscar este autor en
Sciendo|Google Scholar
Zhu, Hong
  
13 abr 2022
Fingolimod exerts in vitro anticancer activity against hepatocellular carcinoma cell lines via YAP/TAZ suppression's Cover Image
Acerca de este artículo
Artículo anterior
Artículo siguiente
Cite
Descargar portada
Publicado en línea: 13 abr 2022
Páginas: 427 - 436
Aceptado: 19 ene 2022
DOI: https://doi.org/10.2478/acph-2022-0029
Palabras clave
© 2022 Jiamin Du et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Idioma:
Inglés
Calendario de la edición:
4 veces al año
Temas de la revista:
Farmacia, Farmacia, otros
RSS Feed de revista